Activated Hepatic Stellate Cells (HSCs) Exert Immunosuppressive Effects in Hepatocellular Carcinoma by Producing Complement C3

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s234920
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Activated Hepatic Stellate Cells Promote Hepatocellular Carcinoma Cell Migration and Invasion via the Activation of FAK-MMP9 Signaling

Oncology Reports
MedicineCancer ResearchOncology
2013English

Soluble FGL2, a Novel Effector Molecule of Activated Hepatic Stellate Cells, Regulates T-Cell Function in Cirrhotic Patients With Hepatocellular Carcinoma

Hepatology International
Hepatology
2014English

Hepatic Stellate Cells Transmigration and Remodeling Are Related to CCN3 in Oxaliplatin-Resistant Hepatocellular Carcinoma

Oncotarget
Oncology
2018English

Activated Hepatic Stellate Cells: Negative Regulators of Hepatocyte Proliferation in Liver Diseases

Hepatology
MedicineHepatology
2012English

Systemic PEGylated TRAIL Treatment Ameliorates Liver Cirrhosis in Rats by Eliminating Activated Hepatic Stellate Cells

Hepatology
MedicineHepatology
2016English

B7-H4 Mediates Inhibition of T Cell Responses by Activated Murine Hepatic Stellate Cells

Hepatology
MedicineHepatology
2010English

Hypoxia-Induced Secretion of Platelet-Derived Growth Factor-Bb by Hepatocellular Carcinoma Cells Increases Activated Hepatic Stellate Cell Proliferation, Migration and Expression of Vascular Endothelial Growth Factor-A

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2014English

Angiotensinogen-Producing Hepatocellular Carcinoma.

Hypertension
Internal Medicine
1984English

High Immunosuppressive Burden in Advanced Hepatocellular Carcinoma Patients

OncoImmunology
OncologyAllergyImmunology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy